Sexual Wellness
PT-141
- Size
- 10 mg
- Form
- Lyophilized powder
- Purity
- ≥ 99% (per COA)
- COA
- Linked per batch
$60.00
Build a stack of 5+ compounds for 20% off — your protocol totals live in the bench tray, with the research-use-only acknowledgment captured at checkout.
For laboratory research use only · Not for human consumption
Reference data
PT-141 (bremelanotide) is a cyclic heptapeptide analogue of alpha-melanocyte-stimulating hormone with a lactam bridge.
- Class
- Melanocortin-receptor agonist (cyclic heptapeptide)
- Also known as
- Bremelanotide · PT-141 · Vyleesi
- Molecular formula
- C50H68N14O10
- Molar mass
- 1025.16 g/mol
- CAS number
- 189691-06-3
- PubChem CID
- 9941379
- Appearance
- White to off-white lyophilized powder
- Storage
- Store lyophilized at -20 °C, protected from light. After reconstitution, keep refrigerated at 2–8 °C.
- Reconstitution
- Reconstitute with bacteriostatic or sterile water; concentration follows the target volume (see the reconstitution calculator).
Sequence
Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH
Authoritative references
Reference data is provided for laboratory identification only. Values are sourced from public chemistry databases; confirm against the batch COA. Not for human or animal use.
Quality & testing
Every batch is independently third-party tested for identity, mass, and purity, and ships with a lot code you can verify. How we test →
- Purity spec
- ≥99%
- Verified by
- Chromate
- Lot
- 33594
- Status
- Independently verified
Dial it in
Reconstitution Calculator
5.00mg/mL
5,000 mcg/mL
5.0units
on a U-100 syringe
Measurement math for laboratory research only. Not dosing guidance, medical advice, or a therapeutic claim.
Product reviews
Ratings reflect product quality — purity, labeling, packaging, reconstitution, and shipping. Research use only.
No reviews yet. Be the first to rate this product.
Sign in to leave a product-quality review.
Pairs well with
Complete the stack
Compounds researchers commonly explore alongside PT-141. Build a stack of 5+ distinct compounds and 20% comes off the whole protocol (supplies excluded).
Pairings reflect compounds commonly researched together — not a protocol, combination guidance, or any therapeutic claim. Research use only.